Gabelli & Co Investment Advisers’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-233,600	Closed	-$1.15M	–	279
2024 Q1	$1.15M	Buy	+233,600	New	+$1.11M	0.2%	78

Gabelli & Co Investment Advisers's TGAN Position: Q2 2024 in Review

Gabelli & Co Investment Advisers sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 233,600 shares — an estimated $1.15M sold.

Gabelli & Co Investment Advisers first reported a position in TGAN in Q1 2024 and held it in 1 quarter. The position peaked at $1.15M in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Gabelli & Co Investment Advisers reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 233,600 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $1.15M.
Gabelli & Co Investment Advisers first reported a position in Transphorm, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Transphorm, Inc. Common Stock position peaked at $1.15M in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2024, filed 13 Aug 2024.